Technology
ALZAI reports validation of Alzheimer’s risk identification models
ALZAI Health announced validation of its AI-driven Alzheimer's disease risk identification models using data from over 1.1 million US patients. The models leverage machine learning to identify individuals at risk of cognitive decline, supporting early detection and intervention pathways in clinical and screening settings.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network